They may also help to identify mechanisms responsible for lung destruction in COPD, which in turn could identify new treatment targets that bronchodilators – although a mainstay of therapy ...

Verona's approval of ensifentrine in COPD offers promising potential with its MoA and safety profile in a competitive market.

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...

A new study from KRIMS Hospital highlights that a staggering 81% of Chronic Obstructive Pulmonary Disease (COPD) patients skip regular treatment, raising concerns about disease management. Dr. Ashok ...

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients.

Benralizumab, a monoclonal antibody, is the first breakthrough in asthma and COPD flare-up treatment in 50 years. Targeting ...